Showing results (221-230 of 235) with videos related to
Sort By:
Pageof 24
Plos Biology|July 15, 2020
Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0Nathalie Percie du Sert, Amrita Ahluwalia, Sabina Alam, et al.BMJ Open Science|June 7, 2021
The ARRIVE guidelines 2.0: updated guidelines for reporting animal researchNathalie Percie du Sert, Viki Hurst, Amrita Ahluwalia, et al.The Journal of Physiology|July 16, 2020
The ARRIVE guidelines 2.0: updated guidelines for reporting animal researchNathalie Percie du Sert, Viki Hurst, Amrita Ahluwalia, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|July 15, 2020
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal researchNathalie Percie du Sert, Viki Hurst, Amrita Ahluwalia, et al.Experimental Physiology|July 16, 2020
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal researchNathalie Percie du Sert, Viki Hurst, Amrita Ahluwalia, et al.International Journal of Stroke : Official Journal of the International Stroke Society|December 23, 2011
A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND)Henry Ma, Mark W Parsons, Soren Christensen, et al.BMC Veterinary Research|July 15, 2020
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal researchNathalie Percie du Sert, Viki Hurst, Amrita Ahluwalia, et al.British Journal of Pharmacology|July 15, 2020
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal researchNathalie Percie du Sert, Viki Hurst, Amrita Ahluwalia, et al.Stroke|November 23, 2022
Ultra-Long Transfers for Endovascular Thrombectomy-Mission Impossible?: The Australia-New Zealand ExperienceCarlos Garcia-Esperon, Teddy Y Wu, Vinicius Carraro do Nascimento, et al.The Lancet. Neurology|October 31, 2020
Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trialAtte Meretoja, Nawaf Yassi, Teddy Y Wu, et al.Pageof 24